推进氯胺酮在难治性抑郁症治疗层次中的应用

The British Journal of Psychiatry Pub Date : 2024-10-25 DOI:10.1192/bjp.2024.217

Kabir Nigam, Franklin King IV, Fernando Espi Forcen

{"title":"推进氯胺酮在难治性抑郁症治疗层次中的应用","authors":"Kabir Nigam, Franklin King IV, Fernando Espi Forcen","doi":"10.1192/bjp.2024.217","DOIUrl":null,"url":null,"abstract":"<p>Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for refractory depression. This, combined with data on psychiatric treatment outcome mediators, suggests that earlier intervention with ketamine could improve outcomes for patients suffering from refractory depression.</p>","PeriodicalId":22495,"journal":{"name":"The British Journal of Psychiatry","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Advancing ketamine in the treatment hierarchy for refractory depression\",\"authors\":\"Kabir Nigam, Franklin King IV, Fernando Espi Forcen\",\"doi\":\"10.1192/bjp.2024.217\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for refractory depression. This, combined with data on psychiatric treatment outcome mediators, suggests that earlier intervention with ketamine could improve outcomes for patients suffering from refractory depression.</p>\",\"PeriodicalId\":22495,\"journal\":{\"name\":\"The British Journal of Psychiatry\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The British Journal of Psychiatry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1192/bjp.2024.217\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The British Journal of Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1192/bjp.2024.217","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

有证据表明，与许多治疗难治性抑郁症的增强策略相比，氯胺酮疗效高、副作用小、耐受性好。这一点与精神科治疗结果介导因素的数据相结合，表明尽早使用氯胺酮进行干预可改善难治性抑郁症患者的治疗结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Advancing ketamine in the treatment hierarchy for refractory depression

Evidence indicates that ketamine is highly effective, has a lower side effect profile and is better tolerated compared to many augmentation strategies for refractory depression. This, combined with data on psychiatric treatment outcome mediators, suggests that earlier intervention with ketamine could improve outcomes for patients suffering from refractory depression.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

The British Journal of Psychiatry

自引率

0.00%

发文量